Thermo Fisher Scientific announced earnings per share of $7.09 on revenue of $10.55B. Analysts polled by Investing.com anticipated EPS of $6.52 on revenue of $9.54B.
Thermo Fisher Scientific shares are up 9% from the beginning of the year, still down 4.29% from its 52 week high of $532.57 set on November 6, 2020. They are outperforming the S&P 500 which is down 1.11% from the start of the year.
Thermo Fisher Scientific’s report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.
Abbott Labs had beat expectations on Wednesday with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar